Literature DB >> 9625028

Visceral leishmaniasis (Kala-Azar) in transplant recipients: case report and review.

J Berenguer1, F Gómez-Campderá, B Padilla, M Rodríguez-Ferrero, F Anaya, S Moreno, F Valderrábano.   

Abstract

BACKGROUND: In endemic areas, visceral leishmaniasis has been identified as an opportunistic infection in patients with derangements in their cellular immune system.
METHODS: We report a renal transplant patient with visceral leishmaniasis. We also reviewed the previously published cases of 17 organ transplant recipients with this parasitic disease.
RESULTS: Visceral leishmaniasis occurred a median time of 8 months after transplantation, and the clinical picture was characterized by fever, splenomegaly, and blood cytopenias. Leishmaniae were detected in bone marrow in 16 of 18 patients and diagnostic serology results were found in 8 of 10 tested patients. Pentavalent antimonials were used to treat 16 patients, five of which developed pancreatitis. Five of 18 patients died, including two untreated patients. Relapses of visceral leishmaniasis occurred in 4 of 13 survivors.
CONCLUSIONS: In endemic areas, visceral leishmaniasis may complicate the clinical course of organ transplantation and can have fatal consequences, particularly when untreated.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9625028     DOI: 10.1097/00007890-199805270-00022

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  9 in total

1.  Probing elongating and branching β-D-galactosyltransferase activities in Leishmania parasites by making use of synthetic phosphoglycans.

Authors:  Olga V Sizova; Andrew J Ross; Irina A Ivanova; Vladimir S Borodkin; Michael A J Ferguson; Andrei V Nikolaev
Journal:  ACS Chem Biol       Date:  2011-04-11       Impact factor: 5.100

Review 2.  Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis.

Authors:  Melanie Walker; James G Kublin; Joseph R Zunt
Journal:  Clin Infect Dis       Date:  2005-11-23       Impact factor: 9.079

Review 3.  Transmission of tropical and geographically restricted infections during solid-organ transplantation.

Authors:  P Martín-Dávila; J Fortún; R López-Vélez; F Norman; M Montes de Oca; P Zamarrón; M I González; A Moreno; T Pumarola; G Garrido; A Candela; S Moreno
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 4.  Leishmaniasis treatment--a challenge that remains: a review.

Authors:  Dilvani O Santos; Carlos E R Coutinho; Maria F Madeira; Carolina G Bottino; Rodrigo T Vieira; Samara B Nascimento; Alice Bernardino; Saulo C Bourguignon; Suzana Corte-Real; Rosa T Pinho; Carlos Rangel Rodrigues; Helena C Castro
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

5.  Cytomegalovirus and Leishmania donovani coinfection in a renal allograft recipient.

Authors:  N Prasad; A Gupta; R K Sharma; S Gopalakrishnan; V Agrawal; M Jain
Journal:  Indian J Nephrol       Date:  2011-04

6.  Atypical presentation of cutaneous leishmaniasis in a renal transplant recipient successfully treated with allopurinol and fluconazole.

Authors:  Soumaya Yaich; Khaled Charfeddine; Abderrahmen Masmoudi; Mondher Masmoudi; Sawssen Zaghdhane; Hamida Turki; Jamil Hachicha
Journal:  Ann Saudi Med       Date:  2012-07-01       Impact factor: 1.526

Review 7.  Solid Organ Transplant and Parasitic Diseases: A Review of the Clinical Cases in the Last Two Decades.

Authors:  Silvia Fabiani; Simona Fortunato; Fabrizio Bruschi
Journal:  Pathogens       Date:  2018-07-31

8.  Donor acquired visceral leishmaniasis following liver transplantation.

Authors:  Amritpal Dhaliwal; Abhishek Chauhan; Dinesh Aggarwal; Pretin Davda; Miruna David; Rasoul Amel-Kashipaz; Rachel Brown; Martin Dedicoat; Fiona Clark; Tahir Shah; Ahmed Mohamed Elsharkawy; Ines Ushiro-Lumb; Peter Chiodini; Omar El-Sherif; Matthew Armstrong; James W Ferguson
Journal:  Frontline Gastroenterol       Date:  2021-01-04

9.  PANCREATIC TOXICITY AS AN ADVERSE EFFECT INDUCED BY MEGLUMINE ANTIMONIATE THERAPY IN A CLINICAL TRIAL FOR CUTANEOUS LEISHMANIASIS.

Authors:  Marcelo Rosandiski Lyra; Sonia Regina Lambert Passos; Maria Inês Fernandes Pimentel; Sandro Javier Bedoya-Pacheco; Cláudia Maria Valete-Rosalino; Erica Camargo Ferreira Vasconcellos; Liliane Fatima Antonio; Mauricio Naoto Saheki; Mariza Mattos Salgueiro; Ginelza Peres Lima Santos; Madelon Noato Ribeiro; Fatima Conceição-Silva; Maria Fatima Madeira; Jorge Luiz Nunes Silva; Aline Fagundes; Armando Oliveria Schubach
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2016-09-22       Impact factor: 1.846

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.